55I, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
55I, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2022$418,000
-25.4%
10,907
-37.6%
0.01%
-28.6%
Q4 2021$560,000
+1.6%
17,489
-6.5%
0.01%
-12.5%
Q3 2021$551,000
+55.2%
18,710
+79.1%
0.02%
+23.1%
Q2 2021$355,000
+11.3%
10,446
+6.6%
0.01%
-18.8%
Q1 2021$319,000
+6.3%
9,801
+27.9%
0.02%
-40.7%
Q3 2020$300,0007,6660.03%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders